Drugs / Potassium supplementation
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03833089 | Mar 2019 → May 2025 overdue | atrial fibrillation, potassium deficiency disease, ventricular tachycardia | Rigshospitalet, Denmark | Active not recruiting | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Potassium supplementation | “3) Potassium supplementation” NCT03833089 ↗ |